DELLAVEDOVA, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 37
AS - Asia 28
NA - Nord America 15
OC - Oceania 1
Totale 81
Nazione #
US - Stati Uniti d'America 15
IT - Italia 13
IE - Irlanda 12
HK - Hong Kong 11
CN - Cina 8
GB - Regno Unito 4
KR - Corea 4
IN - India 3
FI - Finlandia 2
FR - Francia 2
NL - Olanda 2
AU - Australia 1
CH - Svizzera 1
DE - Germania 1
JP - Giappone 1
SG - Singapore 1
Totale 81
Città #
Dublin 11
Hong Kong 11
Milan 5
Turin 3
Boston 2
Chengdu 2
Los Angeles 2
Manchester 2
New York 2
Orléans 2
Perugia 2
Rotterdam 2
San Francisco 2
Santa Cruz 2
Seoul 2
Shanghai 2
Yeonsu-gu 2
Bethesda 1
Delhi 1
Desio 1
Dietikon 1
Dongguan 1
Frankfurt am Main 1
Helsinki 1
Lappeenranta 1
Melzo 1
Peterborough 1
Potomac 1
San Marcos 1
Singapore 1
Tokyo 1
Totale 70
Nome #
STRATEGIES TO OVERCOME OLAPARIB DRAWBACKS: FROM PATIENT SELECTION TO NOVEL THERAPIES 52
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases 17
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin 16
The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer 10
Totale 95
Categoria #
all - tutte 549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202495 0 0 0 15 5 6 7 36 4 15 7 0
Totale 95